Načítá se...

Adoptive Cellular Therapy using Cells Enriched for NKG2D(+)CD3(+)CD8(+)T Cells after Autologous Transplantation for Myeloma

The number of circulating lymphocytes on day 15 after transplantation correlates with improved survival in patients with myeloma, but the lymphocyte subset responsible is unknown. NKG2D is a natural killer (NK) cell activating receptor that mediates non-MHC restricted and TCR-independent cell lysis....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Meehan, Kenneth R., Talebian, Laleh, Tosteson, Tor D., Hill, John M., Szczepiorkowski, Zbigniew, Sentman, Charles L., Ernstoff, Marc S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3772513/
https://ncbi.nlm.nih.gov/pubmed/22975165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.08.018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!